# TERIPARATIDE
> **ANDA211097** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2023-11-16
## Drug
- **FDA Application Number:** ANDA211097
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TERIPARATIDE
- **Generic name:** Teriparatide
- **Active ingredients:** TERIPARATIDE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** APOTEX
- **First approval:** 2023-11-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211097)
---
*MORVS · CC0 1.0*